Type of treatment | Group 1 | Group 2 | P-value |
---|---|---|---|
Ventilatory support | |||
FiO2 | 0.5 ± 0.2 | 0.4 ± 0.1 | 0.25 |
PEEP(cmH2O) | 7.5 ± 1.5 | 9.0 ± 3.6 | 0.54 |
Nutritional support | |||
Total daily caloric intake (kcal/kg/day) | 19.5 ± 3.4 | 23.7 ± 8.1 | 0.14 |
Carbohydrate caloric intake (kcal/kg/day) | 9.7 ± 4.1 | 10.9 ± 4.9 | 0.56 |
Enteral nutrition | |||
Number of patients (%) | 9 (64) | 10 (66) | 0.70 |
Enterak daily caloric intake (kcal/kg/day) | 11.3 ± 7.4 | 17.3 ± 6.4 | 0.11 |
Hemodynamic support (norepinephrine infusion) | |||
Number of patients treated | 8 | 5 | 0.27 |
norepinephrine infusion rate (μg/kg/min) | 0.3 ± 0.2 | 0.4 ± 0.2 | 0.43 |
Antibiotics* | |||
Number of patients treated | 14 | 15 | 1.0 |
Insulin infusion (U/day) | 140.7 ± 56.3 | 67.2 ± 44.9 | < 0.01 |
Corticosteroid treatment (methylprednisolone) | |||
Number of patients treated | 10 | 7 | 0.47 |
methylprednisolone dosage (mg/day) | 160 ± 84 | 200 ± 0 | 0.27 |
Hemodialysis | |||
Number of patients | 2 | 1 | 0.60 |
Blood transfusion | |||
Number of patients | 1 | 1 | 0.62 |